Jain A
Urol Case Rep. 2023; 46:102317.
PMID: 36687749
PMC: 9852599.
DOI: 10.1016/j.eucr.2023.102317.
Levidou G, Klein T, Schaefer-Eckart K, Huettenbrink C, Manava P
Cureus. 2022; 14(5):e24656.
PMID: 35663681
PMC: 9156898.
DOI: 10.7759/cureus.24656.
Vallilas C, Zachou M, Dolkiras P, Sakellariou S, Constantinou C, Flevari P
Am J Case Rep. 2021; 22:e933006.
PMID: 34654796
PMC: 8525903.
DOI: 10.12659/AJCR.933006.
Alves Branco E, Duro R, Brito T, Sarmento A
Infect Dis Rep. 2021; 13(3):611-618.
PMID: 34287340
PMC: 8293128.
DOI: 10.3390/idr13030057.
Itai M, Yamasue M, Takikawa S, Komiya K, Takeno Y, Igarashi Y
BMC Pulm Med. 2021; 21(1):115.
PMID: 33827514
PMC: 8028358.
DOI: 10.1186/s12890-021-01475-w.
Liposome-Encapsulated Bacillus Calmette-Guérin Cell Wall Skeleton Enhances Antitumor Efficiency for Bladder Cancer In Vitro and In Vivo via Induction of AMP-Activated Protein Kinase.
Whang Y, Yoon D, Hwang G, Yoon H, Park S, Choi Y
Cancers (Basel). 2020; 12(12).
PMID: 33302414
PMC: 7762541.
DOI: 10.3390/cancers12123679.
[Development and treatment of localized/systemic BCGitis : Retrospective studies in direct comparison to mitomycin C].
Bohm W, Koch R, Wenzel S, Wirth M, Toma M
Urologe A. 2018; 57(5):568-576.
PMID: 29500474
DOI: 10.1007/s00120-018-0605-7.
Systemic BCG infection in a patient with pancytopaenia and fever 9 years after intravesical BCG administration for bladder cancer.
Westhovens I, Vanden Abeele M, Messiaen P, van der Hilst J
BMJ Case Rep. 2016; 2016.
PMID: 27170615
PMC: 4885450.
DOI: 10.1136/bcr-2016-215599.
Preclinical evaluation of VAX-IP, a novel bacterial minicell-based biopharmaceutical for nonmuscle invasive bladder cancer.
Tsuji S, Chen X, Hancock B, Hernandez V, Visentin B, Reil K
Mol Ther Oncolytics. 2016; 3:16004.
PMID: 27119118
PMC: 4824562.
DOI: 10.1038/mto.2016.4.
Prophylactic vaccines are potent activators of monocyte-derived dendritic cells and drive effective anti-tumor responses in melanoma patients at the cost of toxicity.
Bol K, Aarntzen E, Pots J, Olde Nordkamp M, van de Rakt M, Scharenborg N
Cancer Immunol Immunother. 2016; 65(3):327-39.
PMID: 26861670
PMC: 4779136.
DOI: 10.1007/s00262-016-1796-7.
Bacillus Calmette-Guérin (BCG) infection following intravesical BCG administration as adjunctive therapy for bladder cancer: incidence, risk factors, and outcome in a single-institution series and review of the literature.
Perez-Jacoiste Asin M, Fernandez-Ruiz M, Lopez-Medrano F, Lumbreras C, Tejido A, San Juan R
Medicine (Baltimore). 2014; 93(17):236-254.
PMID: 25398060
PMC: 4602419.
DOI: 10.1097/MD.0000000000000119.
Bacillus calmette-guerin infection in NADPH oxidase deficiency: defective mycobacterial sequestration and granuloma formation.
Deffert C, Schappi M, Pache J, Cachat J, Vesin D, Bisig R
PLoS Pathog. 2014; 10(9):e1004325.
PMID: 25188296
PMC: 4154868.
DOI: 10.1371/journal.ppat.1004325.
Mycobacterium bovis spondylodiscitis after intravesical Bacillus Calmette-Guérin therapy.
Obaid S, Weil A, Rahme R, Gendron C, Shedid D
Surg Neurol Int. 2011; 2:162.
PMID: 22140647
PMC: 3228380.
DOI: 10.4103/2152-7806.89879.
A case of Pott's disease with epidural abscess and probable cerebral tuberculoma following Bacillus Calmette-Guérin therapy for superficial bladder cancer.
Josephson C, Al-Azri S, Smyth D, Haase D, Johnston B
Can J Infect Dis Med Microbiol. 2011; 21(1):e75-8.
PMID: 21358881
PMC: 2852295.
DOI: 10.1155/2010/572410.
Peritoneal tuberculosis and granulomatous hepatitis secondary to treatment of bladder cancer with Bacillus Calmette-Guérin.
Soylu A, Ince A, Polat H, Yasar N, Ciltas A, Ozkara S
Ann Clin Microbiol Antimicrob. 2009; 8:12.
PMID: 19368735
PMC: 2672069.
DOI: 10.1186/1476-0711-8-12.
[Sepsis and multiple organ failure after BCG-instillation for bladder cancer].
Elmer A, Bermes U, Drath L, Buscher E, Viertel A
Internist (Berl). 2004; 45(8):935-9.
PMID: 15138643
DOI: 10.1007/s00108-004-1205-8.
Mycobacterium bovis BCG recA deletion mutant shows increased susceptibility to DNA-damaging agents but wild-type survival in a mouse infection model.
Sander P, Papavinasasundaram K, Dick T, Stavropoulos E, Ellrott K, Springer B
Infect Immun. 2001; 69(6):3562-8.
PMID: 11349014
PMC: 98336.
DOI: 10.1128/IAI.69.6.3562-3568.2001.
Granulomatous hepatitis caused by Bacillus Calmette-Guerin (BCG) infection after BCG bladder instillation.
Leebeek F, Ouwendijk R, Kolk A, Dees A, MEEK J, Nienhuis J
Gut. 1996; 38(4):616-8.
PMID: 8707098
PMC: 1383125.
DOI: 10.1136/gut.38.4.616.